KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Return on Equity (2016 - 2025)

Biogen (BIIB) has 15 years of Return on Equity data on record, last reported at 0.18% in Q3 2025.

  • For Q3 2025, Return on Equity changed N/A year-over-year to 0.18%; the TTM value through Sep 2025 reached 0.18%, changed N/A, while the annual FY2024 figure was 0.1%, 2.0% up from the prior year.
  • Return on Equity reached 0.18% in Q3 2025 per BIIB's latest filing, up from 0.09% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.29% in Q1 2021 and bottomed at 0.07% in Q2 2024.
  • Average Return on Equity over 5 years is 0.16%, with a median of 0.15% recorded in 2021.
  • Peak YoY movement for Return on Equity: fell -28bps in 2021, then rose 10bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.15% in 2021, then fell by -13bps to 0.13% in 2022, then surged by 49bps to 0.2% in 2023, then crashed by -64bps to 0.07% in 2024, then surged by 152bps to 0.18% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.18% in Q3 2025, 0.09% in Q2 2025, and 0.09% in Q1 2025.